Saffron and low mood
What an Activ’Inside study found in people with subclinical symptoms.
Key points
- In adults without a diagnosed mental disorder but with symptoms of low mood, anxiety, fatigue or stress, Activ’Inside showed no advantage over placebo in the overall rating of mood, anxiety and fatigue over six weeks. This study does not support relying on an established improvement in these measures when choosing this extract. [1] See the evidence 1
- The Activ’Inside studied was a distinct standardized extract, not culinary saffron. Check the specific form when comparing supplements: this trial’s result concerns that form. [1] [2] [3] See the evidence 1 2
Practical guide
Check the conclusions and whether they apply to your situation.
Mood, anxiety and fatigue were assessed in a specific group of adults.
Key points
Why these conclusions
The Activ’Inside study
Adults with subclinical depressive symptoms took 15 mg standardized Activ’Inside extract twice daily with breakfast and dinner or placebo for six weeks. No advantage was shown for the overall rating of low mood, anxiety and fatigue or its individual components. [1]
Saffron is the dried stigmas of Crocus sativus. The spice, standardized Safr’Inside extract and individual saffron compounds differ in composition; the RCT result concerns the extract studied. [2] [3]
Gastrointestinal adverse events, usually mild, have been reported in saffron studies; not all studies collected them systematically. [4]
Activ’Inside showed no advantage over placebo in the composite measure of low mood, anxiety and fatigue or its individual components.
| Parameter | Data |
|---|---|
| Result | Activ’Inside showed no advantage over placebo in the composite measure of low mood, anxiety and fatigue or its individual components. No significant between-group difference was shown for the composite or its individual components. |
| Participants | 51 adults with subclinical depressive symptoms |
| Form | Activ’Inside extract, >2.5% crocins and >1.5% safranal using the specified different analytical methods |
| Dose | 15 mg twice daily with breakfast and dinner |
| Dose basis | 15 mg twice daily with breakfast and dinner |
| Comparator | Maltodextrin |
| Duration | 6 weeks |
| Confidence | 2/4: risk_of_bias: multiple outcomes and self-ratings.; inconsistency: no grounds for a separate downgrade.; indirectness: the measure directly addresses the specified narrow PICO.; imprecision: 51 participants; exact CI of the comparative effect not confirmed.; publication_bias: no specific data for a separate downgrade. |
| Evidence base | 1 trial |
| Sources | [1] |
Saffron is the dried stigmas of Crocus sativus. The spice, standardized Safr’Inside extract and individual saffron compounds differ in composition; the RCT result concerns the extract studied.
Saffron is the dried stigmas of Crocus sativus. The spice, standardized Safr’Inside extract and individual saffron compounds differ in composition; the RCT result concerns the extract studied. [2] [3]
Gastrointestinal adverse events, usually mild, have been reported in saffron studies; not all studies collected them systematically.
Gastrointestinal adverse events, usually mild, have been reported in saffron studies; not all studies collected them systematically. [4]
More details
Which formulation the result concerns
Standardized Activ’Inside was studied; the conclusion concerns this product and the specified group. [1]
Sources
- Effect of saffron extract supplementation on mood in healthy adults with subclinical symptoms of depression: a randomized, double-blind placebo-controlled study.. https://pubmed.ncbi.nlm.nih.gov/41047129/
- CPG Sec 525.750 Spices - Definitions. https://www.fda.gov/regulatory-information/search-fda-guidance-documents/cpg-sec-525750-spices-definitions
- Effect of a saffron extract on sleep quality in adults with moderate insomnia: A decentralized, randomized, double-blind, placebo-controlled trial. https://pmc.ncbi.nlm.nih.gov/articles/PMC12281372/
- Adverse Events of Saffron (Crocus sativus L.): Systematic Review of Current Evidence. https://pubmed.ncbi.nlm.nih.gov/42057871/
Methodology: Subpages evidence-led supplement pipeline v1